October 4, 2017 — Medtronic received U.S. Food and Drug Administration (FDA) approval for its HeartWare HVAD System as a ...
Diagnostic and Interventional Cardiology DAIC
Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.
October 04, 2017
October 3, 2017 — Despite expectations to the contrary, a new survey from cardiovascular healthcare consulting firm ...
October 03, 2017October 2, 2017 — Cardiovascular healthcare membership organization and performance community MedAxiom announced its ...
October 02, 2017
October 2, 2017 — Medtronic recently announced a new post-market clinical study to evaluate its CoreValve Evolut Pro ...
October 02, 2017
September 28, 2017 — Abiomed Inc. recently received U.S. Food and Drug Administration (FDA) pre-market approval (PMA) ...
September 28, 2017
September 27, 2017 — Boston Scientific recently launched the Resonate family of implantable cardioverter defibrillator ...
September 27, 2017
September 27, 2017 — Toshiba Medical announced it will highlight several of its latest vascular and interventional ...
September 27, 2017
September 26, 2017 — BioCardia Inc. recently announced 12-month results from the Phase II TRIDENT clinical trial ...
September 26, 2017September 26, 2017 — The one-year results of the SENTRY clinical trial were presented by principal investigator Michael ...
September 26, 2017
September 25, 2017 — BioCardia Inc. announced the trial design for its pivotal Phase III CardiAMP Heart Failure Trial ...
September 25, 2017
September 22, 2017 — The Montreal Heart Institute (MHI) announced the acquisition of the da Vinci Xi, a new-generation s ...
September 22, 2017
September 21, 2017 — Edwards Lifesciences Corp. recently received U.S. Food and Drug Administration (FDA) approval for ...
September 21, 2017
September 21, 2017 — MyoKardia Inc. announced that additional positive data from the first patient cohort of its Phase 2 ...
September 21, 2017
September 19, 2017 — The heart failure space across the seven key markets of the U.S., France, Germany, Italy, Spain ...
September 19, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the Journal of the American College of ...
September 18, 2017